SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,460,521 | -65.8% | 70,968 | -46.3% | 0.01% | -68.2% |
Q2 2022 | $4,267,000 | +190.1% | 132,101 | +197.3% | 0.02% | +175.0% |
Q1 2022 | $1,471,000 | -74.2% | 44,440 | -66.9% | 0.01% | -74.2% |
Q4 2021 | $5,711,000 | -46.3% | 134,245 | -44.1% | 0.03% | -55.1% |
Q3 2021 | $10,644,000 | +27.9% | 240,207 | +63.9% | 0.07% | +19.0% |
Q2 2021 | $8,325,000 | -33.4% | 146,546 | -12.3% | 0.06% | -36.3% |
Q1 2021 | $12,504,000 | -17.3% | 167,059 | -4.4% | 0.09% | -28.3% |
Q4 2020 | $15,113,000 | +49.6% | 174,699 | +5.7% | 0.13% | +51.2% |
Q3 2020 | $10,100,000 | -30.1% | 165,247 | -52.4% | 0.08% | -49.1% |
Q2 2020 | $14,443,000 | +146.8% | 347,353 | +70.5% | 0.16% | -1.8% |
Q1 2020 | $5,851,000 | +389.6% | 203,712 | +1130.8% | 0.17% | +630.4% |
Q4 2019 | $1,195,000 | -51.4% | 16,551 | -5.6% | 0.02% | -46.5% |
Q3 2019 | $2,458,000 | -72.3% | 17,524 | -67.5% | 0.04% | -77.8% |
Q4 2017 | $8,879,000 | +50.7% | 53,908 | -27.1% | 0.19% | +32.0% |
Q2 2017 | $5,890,000 | -0.6% | 73,953 | -11.3% | 0.15% | +2.1% |
Q1 2017 | $5,924,000 | +130.8% | 83,353 | +65.8% | 0.14% | +161.8% |
Q4 2016 | $2,567,000 | – | 50,266 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
Diametric Capital, LP | 19,393 | $626,000 | 0.46% |